IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

ZATTARIN, EMMA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 148
EU - Europa 120
AS - Asia 32
OC - Oceania 1
Totale 301
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 147
SE - Svezia 44
IT - Italia 29
IE - Irlanda 18
GB - Regno Unito 14
CN - Cina 11
VN - Vietnam 8
FR - Francia 7
IN - India 5
DE - Germania 4
ID - Indonesia 4
BE - Belgio 3
JP - Giappone 3
AU - Australia 1
CA - Canada 1
DK - Danimarca 1
KR - Corea 1
Totale 301
Salva come PNG Salva come JPEG
Città #
Chandler 74
Dublin 18
Princeton 10
Dong Ket 8
Phoenix 8
Southend 8
Rho 6
Milan 5
Wilmington 5
London 4
Brussels 3
Medford 3
Ashburn 2
Berlin 2
Cambridge 2
Casorate Primo 2
Manchester 2
Menlo Park 2
Monza 2
Upper Marlboro 2
Ann Arbor 1
Buffalo 1
Des Moines 1
Drexel Hill 1
Holbaek 1
Kure 1
Montreal 1
Naples 1
Orta di Atella 1
Rome 1
San Diego 1
Seoul 1
Sydney 1
Tokyo 1
Totale 182
Salva come PNG Salva come JPEG
Nome #
Monitoring patients with head and neck cancer for flu-like symptoms during the COVID-19 pandemic 58
Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy 49
Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology 37
Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients 28
Evaluation of drug-drug interactions in EGFR-mutated non-small-cell lung cancer patients during treatment with tyrosine-kinase inhibitors 27
The pan-immune-inflammation-value predicts the survival of patients with human epidermal growth factor receptor 2 (Her2)—positive advanced breast cancer treated with first-line taxane-trastuzumab-pertuzumab 24
Prolonged benefit from palbociclib plus letrozole in heavily pretreated advanced male breast cancer: case report 23
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21) 21
Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancer 18
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin 15
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario 12
Prognostic role of body mass index (BMI) in patients with Human Epidermal growth factor Receptor 2 (HER2)epositive early breast cancer treated with adjuvant trastuzumab-containing chemotherapy 9
Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications 5
Totale 326
Salva come PNG Salva come JPEG
Categoria #
all - tutte 844
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 844
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0000 00 00 0129
2021/202265 0321 42 18 211625
2022/2023249 23251818 2445 523 335291
Totale 326